Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Nutr Metab Cardiovasc Dis ; 25(4): 376-81, 2015 Apr.
Article de Anglais | MEDLINE | ID: mdl-25716098

RÉSUMÉ

BACKGROUND AND AIMS: Carotenoids may reduce diabetes risk, due to their antioxidant properties. However, the association between dietary carotenoids intake and type 2 diabetes risk is still unclear. Therefore, the objective of this study was to examine whether higher dietary carotenoid intakes associate with reduced type 2 diabetes risk. METHODS AND RESULTS: Data from 37,846 participants of the European Prospective Investigation into Cancer and Nutrition- Netherlands study were analyzed. Dietary intakes of ß-carotene, α-carotene, ß-cryptoxanthin, lycopene, lutein & zeaxanthin and the sum of these carotenoids were assessed using a validated food frequency questionnaire. Incident type 2 diabetes was mainly self-reported, and verified against general practitioner information. Mean ±SD total carotenoid intake was 10 ± 4 mg/day. During a mean ±SD follow-up of 10 ± 2 years, 915 incident cases of type 2 diabetes were ascertained. After adjustment for age, sex, diabetes risk factors, dietary intake, waist circumference and BMI, higher ß-carotene intakes associated inversely with diabetes risk [Hazard Ratio quartile 4 versus quartile 1 (HR(Q4)): 0.78 (95%CI:0.64,0.95), P-linear trend 0.01]. For α-carotene, a borderline significant reduced risk was observed, with a HR(Q4) of 0.85 (95%CI:0.70,1.03), and P-linear trend 0.05. ß-cryptoxanthin, lycopene, lutein & zeaxanthin, and the sum of all carotenoids did not associate with diabetes risk. CONCLUSIONS: This study shows that diets high in ß-carotene and α-carotene are associated with reduced type 2 diabetes in generally healthy men and women.


Sujet(s)
Antioxydants/administration et posologie , Caroténoïdes/administration et posologie , Diabète de type 2/épidémiologie , Sujet âgé , Cryptoxanthines/administration et posologie , Métabolisme énergétique , Femelle , Études de suivi , Humains , Incidence , Lutéine/administration et posologie , Lycopène , Mâle , Adulte d'âge moyen , Pays-Bas/épidémiologie , Évaluation de l'état nutritionnel , Études prospectives , Facteurs de risque , Enquêtes et questionnaires , Zéaxanthines/administration et posologie , Bêtacarotène/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE